The global vascular grafts market is estimated at US$ 3.73 billion in 2023 and is predicted to climb to a value of US$ 7.04 billion by the end of 2033. As per this detailed Fact.MR research analysis, worldwide demand for vascular grafts is forecasted to rise at a healthy 6.5% CAGR over the next ten years.This robust growth is driven by the surging prevalence of cardiovascular disorders, chronic renal diseases, and aortic aneurysms worldwide. The market is benefiting from an expanding geriatric population, rising healthcare expenditure, and increasing awareness of cardiovascular health. The United States, a key market, is expected to grow at a CAGR of around 5.5% through 2033, reflecting high incidences of heart-related surgeries and advanced medical infrastructure. Globally, the market is shaped by poor lifestyle habits, such as sedentary behavior and high alcohol consumption, alongside supportive government initiatives for early diagnosis and treatment. However, challenges like vascular graft-related infections and a shortage of skilled professionals in emerging economies could impact growth, necessitating ongoing innovation to address these issues and meet regulatory demands.

Vascular Grafts Market Technology Development:

Technological advancements are significantly shaping the vascular grafts industry, with a focus on biocompatibility, durability, and minimally invasive applications. Innovations in tissue-engineered vascular grafts are addressing key challenges like thrombosis, intimal hyperplasia, and graft remodeling. For instance, next-generation grafts made from synthetic materials that mimic natural tissue properties are gaining traction, offering improved performance over traditional options. Companies are developing biosynthetic and polyurethane-based grafts with enhanced flexibility and resistance to infection. The integration of 3D printing and nanotechnology allows for customized grafts tailored to patient anatomy, reducing rejection risks and improving surgical outcomes. Additionally, advancements in endovascular aneurysm repair (EVAR) technologies, such as fenestrated grafts, enable precise placement and faster recovery. These developments align with the growing demand for minimally invasive procedures, which shorten hospital stays and minimize pain compared to open surgeries. Startups are leveraging biotechnology to create bioresorbable grafts that promote natural vessel regeneration, positioning the industry for sustainable growth amid stricter biocompatibility standards and patient-centric care trends.

Vascular Grafts Market Demand and Impact Analysis:

The demand for vascular grafts is primarily driven by the global rise in cardiovascular diseases, affecting over 500 million people worldwide, and chronic kidney disorders requiring hemodialysis access. Rapid aging populations, with over 10% of the global populace aged 65+ in 2025 and projected to reach 16% by 2050, have increased the need for grafts to bypass damaged vessels. In emerging economies like India and China, urbanization and lifestyle changes are fueling a 20-30% annual increase in heart disease cases, boosting graft shipments. Environmental factors, such as poor diets and inactivity, exacerbate these trends, while rising healthcare spending—expected to hit $10 trillion globally by 2030—supports advanced treatments. Regulatory approvals for innovative grafts further propel market expansion. However, risks like graft infections, affecting up to 5% of procedures, and high costs in low-income regions could restrain growth. The shift toward minimally invasive surgeries aligns with patient preferences for quicker recovery, creating opportunities for manufacturers to innovate and capture market share in high-growth segments like EVAR.

Full Market Report available for delivery. For purchase or customization, please request here: https://www.factmr.com/connectus/sample?flag=S&rep_id=7620

Vascular Grafts Market Analysis by Top Investment Segments:

The vascular grafts market is segmented by treatment (endovascular aneurysm repair (EVAR), peripheral vascular repair, and hemodialysis access), raw material (polyester, ePTFE, polyurethane, biosynthetic), end-user (hospitals, ambulatory surgical centers), and region (North America, Latin America, Europe, APAC, MEA). The EVAR segment is the most lucrative, holding over 50% market share in 2025 and projected to grow at a 7% CAGR through 2033, driven by its cost-effectiveness and lower complications compared to open surgeries. This segment accounts for significant investments due to rising aneurysm cases and technological advancements in stent grafts. The hospitals end-user segment dominates with over 60% share, fueled by government funding for advanced equipment and high volumes of cardiovascular procedures. Among raw materials, ePTFE and polyester are favored for their durability and biocompatibility, making them attractive for investment in regions with high surgical demand. High-performance biosynthetic grafts represent a growing opportunity, particularly in APAC and Europe, where regulatory support for innovative materials encourages R&D. Overall, EVAR and hospital segments offer the highest returns, supported by aging demographics and infrastructure development.

Vascular Grafts Market Across Top Countries:

The vascular grafts market exhibits regional variations, with key countries driving growth.

1.China leads due to its rapidly aging population and heavy investments in healthcare infrastructure, with the market projected to grow at 8% CAGR, boosted by awareness campaigns and innovative treatments.

2.India is a high-growth market, driven by increasing cardiovascular incidences and government initiatives like expanded medical access, with demand surging in urban areas.

3.United States remains a significant market, valued at approximately $1.5 billion in 2025, fueled by high obesity rates, sedentary lifestyles, and a surge in minimally invasive surgeries.

4.Japan benefits from advanced early diagnosis systems and a senescent population, contributing to steady graft sales.

5.Europe, particularly Germany, France, and the UK, sees growth from minimally invasive procedure popularity and stringent health regulations, collectively holding a 30% global share. These countries account for substantial demand, with APAC leading overall due to demographic shifts and economic development.

Leading Vascular Grafts Companies and Their Industry Share:

The vascular grafts market is dominated by multinational corporations leveraging R&D and global distribution networks. Key players include Medtronic PLC, Cook Medical, W.L. Gore & Associates Inc., Terumo Medical Corporation, and Getinge Group, which collectively hold over 50% market share. Medtronic and Cook Medical lead with strong portfolios in EVAR grafts and regulatory approvals, such as Cook's FDA breakthrough for fenestrated grafts. W.L. Gore excels in ePTFE-based products, known for durability. Terumo and Getinge focus on biosynthetic innovations, capitalizing on hemodialysis demand. These companies engage in strategic initiatives like funding raises and product launches to maintain competitiveness. Regional players, including startups like Xeltis and Cagent Vascular, contribute to fragmentation in emerging markets but multinationals dominate through quality compliance and scale.

Vascular Grafts Market Historic and Future Pathway Analysis:

Historically, the vascular grafts market has grown steadily, from approximately $2.8 billion in 2018 to $3.73 billion in 2023, driven by rising CVD awareness and technological shifts from traditional to minimally invasive grafts. From 2018 to 2022, the market saw a CAGR of around 5.5%, influenced by post-pandemic recovery and approvals for novel products. Looking forward, the market is expected to accelerate to $7.04 billion by 2033 at 6.5% CAGR, propelled by aging populations and EVAR adoption. Sustainable, tissue-engineered grafts will be key trends, aligning with global health goals. Emerging markets in APAC will drive demand, while challenges like infection risks require R&D investments. Companies must focus on partnerships and innovation to sustain growth.

Read Full Report Now: https://www.factmr.com/report/vascular-grafts-market

Vascular Grafts Industry News:

Recent developments underscore the dynamic nature of the vascular grafts market.

-In April 2025, Medtronic announced an expansion of its EVAR graft portfolio with enhanced fenestrated designs, targeting improved aneurysm treatment efficacy.

-Cook Medical's partnership with a European medtech firm in March 2025 focuses on developing next-gen biosynthetic grafts for hemodialysis.

-In November 2024, W.L. Gore introduced advanced ePTFE coatings to reduce thrombosis, aligning with sustainability trends. These initiatives reflect the industry’s focus on innovation, scalability, and compliance. Additionally, increasing M&A activity and expansions in APAC are creating growth opportunities. The rise of bioengineered solutions and regulatory support for minimally invasive devices are driving investments in R&D and collaborations, ensuring alignment with global health demands.

Explore More Related Studies Published by Fact.MR Research:

Angioplasty Balloons Market- https://www.factmr.com/report/4318/angioplasty-balloons-market

Medical Mask Market- https://www.factmr.com/report/4732/medical-mask-market

Respiratory Virus Vaccines Market- https://www.factmr.com/report/5199/respiratory-virus-vaccines-market

Medical Suction Devices Market- https://www.factmr.com/report/5434/medical-suction-devices-market

Softgel Capsules Market- https://www.factmr.com/report/softgel-capsules-market

Spectrometry Market- https://www.factmr.com/report/spectrometry-market

Neurorehabilitation Devices Market- https://www.factmr.com/report/neurorehabilitation-devices-market

Vascular Grafts Market- https://www.factmr.com/report/vascular-grafts-market

Organs-on-Chips Market- https://www.factmr.com/report/organs-on-chips-market

Critical Care Equipment Market- https://www.factmr.com/report/critical-care-equipment-market

About Fact.MR:

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client’s satisfaction.

Contact:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Sales Team: sales@factmr.com
Follow Us: LinkedIn | Twitter | Blog